Indication
CMV retinitis in immunocompromised patient
Cytomegalovirus (CMV) retinitis in an immunocompromised patient is a serious, vision-threatening opportunistic viral infection of the retina caused by the reactivation of latent human cytomegalovirus. Read more about CMV retinitis in immunocompromised patient
10 drugs 10 manufacturers
Drugs that treat it
Common CMV retinitis in immunocompromised patient therapies.
CYTOVENE (ganciclovir sodium)
GANCICLOVIR SODIUM
GANCICLOVIR
GANCICLOVIR SODIUM
GANCICLOVIR SODIUM
CYTOVENE (ganciclovir sodium)
GANCICLOVIR SODIUM
GANCICLOVIR SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCytomegalovirus (CMV) retinitis in an immunocompromised patient is a serious, vision-threatening opportunistic viral infection of the retina caused by the reactivation of latent human cytomegalovirus.
It predominantly affects individuals with profound cell-mediated immunodeficiency, most commonly those with advanced HIV/AIDS and low CD4 counts, as well as organ transplant recipients and patients receiving intensive immunosuppressive therapy.
Pathophysiologically, uncontrolled viral replication causes necrotizing retinitis characterized by full-thickness retinal necrosis, vascular attenuation, and dense intraretinal hemorrhages, often presenting ophthalmoscopically in a granular or fulminant pattern.
Without timely intervention, the infection characteristically leads to progressive visual field defects, irreversible vision loss, and rhegmatogenous retinal detachment.
- nih.gov
Cytomegalovirus (CMV) retinitis in an immunocompromised patient is a serious, vision-threatening opportunistic viral infection of the retina caused by the reactivation of latent human cytomegalovirus It predominantly affects individuals with profound cell-mediated immunodeficiency, most commonly those with advanced HIV/AIDS and low CD4 counts, as well as organ transplant recipients and patients receiving intensive immunosuppressive therapy
- nih.gov
Cytomegalovirus (CMV) retinitis in an immunocompromised patient is a serious, vision-threatening opportunistic viral infection of the retina caused by the reactivation of latent human cytomegalovirus Pathophysiologically, uncontrolled viral replication causes necrotizing retinitis characterized by full-thickness retinal necrosis, vascular attenuation, and dense intraretinal hemorrhages, often presenting ophthalmoscopically in a granular or fulminant pattern Without timely intervention, the infec...
- nih.gov
Pathophysiologically, uncontrolled viral replication causes necrotizing retinitis characterized by full-thickness retinal necrosis, vascular attenuation, and dense intraretinal hemorrhages, often presenting ophthalmoscopically in a granular or fulminant pattern
- nih.gov
Without timely intervention, the infection characteristically leads to progressive visual field defects, irreversible vision loss, and rhegmatogenous retinal detachment
Personalize your experience
Follow CMV retinitis in immunocompromised patient and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.